EFFECTOR THERAPEUTICS INC (EFTR)
US28202V2079 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 42M | 1.43M -96.60% | 3.553M 148.46% | -100.00% | 76.5M | 213.18M 178.67% | 341.7M 60.29% | 433.5M 26.87% | ||||
| EBITDA YoY % growth | 15.979M 156.47% | -31.873M -299.47% | -32.35M -1.50% | -47.003M -4.28% | -66.535M -97.24% | -82.307M -23.71% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 15.819M 155.30% | -31.897M -301.64% | -32.403M -1.59% | -32.89M -4.45% | -33.471M 1.10% | -36.21M -8.18% | -62.985M -73.94% | -49.215M 21.86% | 29.529M 160.00% | 135.2M 357.85% | 242.25M 79.18% | |
| Operating Margin | 37.66% | -2,230.56% | -911.99% | N/A | N/A | N/A | N/A | -64.33% | 13.85% | 39.57% | 55.88% | |
| EPS YoY % growth | N/A | N/A | -5.83 43.55% | -15.91 -190.22% | -5.74 66.09% | -2.30 60.00% | -0.86 62.67% | -0.71 16.67% | 0.07 110.00% | 1.16 1,528.57% | 2.52 116.67% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -2.06 51.52% | -1.57 51.82% | -0.91 73.31% | -0.20 90.56% | -0.23 88.61% | -0.20 86.97% | -0.18 79.89% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.528M -8.57% | -8.305M -5.73% | -8.044M 6.45% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -2.16 64.00% | -2.21 | 0.05 | 2.19% |
| Q4 2023 Q2Q % growth | -3.42 37.82% | -1.68 | -1.74 | -103.21% |
| Q3 2023 Q2Q % growth | -3.25 -1,313.04% | -3.14 | -0.11 | -3.34% |
| Q2 2023 Q2Q % growth | -4.25 -2,400.00% | -5.04 | 0.79 | 15.72% |
| Q1 2023 Q2Q % growth | -6.00 -8,671.43% | -3.47 | -2.53 | -73.01% |
| Q4 2022 Q2Q % growth | -5.50 -1,350.00% | -6.07 | 0.57 | 9.38% |
| Q3 2022 Q2Q % growth | -0.23 -154.76% | -0.22 | -0.01 | -5.47% |
| Q2 2022 Q2Q % growth | -0.17 | -0.16 | -0.01 | -3.39% |
| Q1 2022 Q2Q % growth | 0.07 | -0.24 | 0.31 | 128.93% |
| Q4 2021 Q2Q % growth | 0.44 | -0.25 | 0.69 | 279.59% |
| Q3 2021 Q2Q % growth | 0.42 | -0.20 | 0.62 | 309.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -100.00% | % | ||
| Q3 2023 Q2Q % growth | -100.00% | % | ||
| Q2 2023 Q2Q % growth | -100.00% | % | ||
| Q4 2022 Q2Q % growth | 675K 117.04% | 677.688K | -2.688K | -0.40% |
| Q3 2022 Q2Q % growth | 867K 103.04% | 655.044K | 211.956K | 32.36% |
| Q2 2022 Q2Q % growth | 2.011M 190.61% | 535.5K | 1.476M | 275.54% |
| Q1 2022 Q2Q % growth | 357K | -357K | -100.00% | |
| Q4 2021 Q2Q % growth | 311K 640.48% | 127.5K | 183.5K | 143.92% |
| Q3 2021 Q2Q % growth | 427K -25.61% | 427K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -16.43% | -20.6% | 0% | -8.7% |
| Revenue | N/A | N/A | N/A | N/A |